Related references
Note: Only part of the references are listed.Cancer risks in first degree relatives of BRCA1 mutation carriers:: effects of mutation and proband disease status
J Gronwald et al.
JOURNAL OF MEDICAL GENETICS (2006)
Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel
G Rennert et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2005)
Breast cancer predisposing alleles in Poland
B Górski et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
BRCA mutations and risk of prostate cancer in Ashkenazi Jews
T Kirchhoff et al.
CLINICAL CANCER RESEARCH (2004)
NBS1 is a prostate cancer susceptibility gene
C Cybulski et al.
CANCER RESEARCH (2004)
Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers
KA Zuhlke et al.
CLINICAL CANCER RESEARCH (2004)
A high proportion of founder BRCA1 mutations in Polish breast cancer families
B Górski et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
CHEK2 variants associate with hereditary prostate cancer
EH Seppälä et al.
BRITISH JOURNAL OF CANCER (2003)
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
RM Giusti et al.
JOURNAL OF MEDICAL GENETICS (2003)
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland -: art. no. e98
T Ikonen et al.
JOURNAL OF MEDICAL GENETICS (2003)
Mutations in CHEK2 associated with prostate cancer risk
XY Dong et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene
SM Edwards et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
A. Vezina et al.
BRITISH JOURNAL OF CANCER (2000)